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ABSTRACT

Derivatives of cyclohexanol were screened for
pharmacological effects on intact

ane~thetized rat~v

iBolated guinea pig heart;s 9 ia \j)la.ted rat atria and isolated rabbit

~ma.11

intestineo

produced a hypotensive
varying

fr~m

All the compounds tested

respon~e

and cardio-inhibitory effects

slight depression to complete arres t o

On the

baais of recovery from induced cardiac arJrest none of the
compounds appeared to be cardio - toxico

All the

compound~

produced inhibitory effects on the isolated small intestine
in varying

degree~o

Methyl

3-hydroxy-2-Q.~to lyl cyclohexylacetate

and

trans-3-oxo-2=.Q.-tolylcyclohexylacetic acid were equally
potent and the most effective in their cardiovascular
whereas the ketal from

glycer ~l

was the most effective on the

and

effect~

2 -Q.=to lylcycl~hexax;Jone

!$~lated

rabbit small

inte~tine.

Studies of mechsnism 9 employing the isolated rat atria,
indicate an antagonistic effect between these
calciumo

c.ompoui.nd.~

end
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I.

INTRODUCTION

The production of elective cardiac arrest has become
of interest within the past decade with the advances made in
open-heart surgery.

During cardiopulmonary by-pass procedures

for the correction of intracardiac lesions, it sometimes is
expedient to utilize adjuvant measures for the temporary control of cardiac per:fusion and activity.

These are valuable

assets to the cardiac surgeon and provide a quiet and dry
field which facilitates the repair of complex cardiac defects.
Experimental and clinical cardioplegia has been
achieved by various techniques.

'l'hese consist chiefly of

inducing cardiac arrest by anoxia, hypothermia, and the use
of substance's such as acetylcholine and potassium citrate.
Other agents and techniques have been introduced and in turn
received with varying degrees of enthusiasm, with none of
them reliable for routine use.

The major complications are

the difficulty in restoring the heart beat, ventricular
fibrillation and arrhythmias, resistance to electrical
stimulation, and myocardial damage.
~e

ideal cardioplegic agent should be able to produce

a prompt and effective cardiac m:-rest that will continue for
a period of time sufficient for the repair of complicated
intracardiac pathology.

It should be nontoxic to the myo-

cardium and other tissues and recovery from arrest should be
rapid, safe and reliable (Fergulio, 1959).

The synthesis of

2

new compounds that could bring about elective cardiac arrest
has progressed at a rapid rate, but the ideal cardioplegic
agent has 7et to be found.
It is evident from various reports in the literature
that several derivatives of c7olohexanol possess oardioplegio
properties.

'?he present investigation deals with the evalua-

tion of newer 07olohexanol derivatives in an effort to f'urther
correlate molecular stl"ll.ot'Uz-e with cardio-inhibitor7 activit7.

II •

REVIEW OF THE LITERATURE

Elective cardiac arrest, induced in the course of open
cardiac operations with cardiopulmonary bypass, has been
found to be a valuable technical adjunct.

In particular,

the quiet and dry field it provides greatly facilitates the
repair of more complex anomalies.
Since this investigation deals with the pharmacological approach to elective cardiac arrest the review of
the literature concerns agents that produce this effect.
'fb.e concept of temporarily abolishing cardiac activity has been known since the latter part of the nineteenth
century.

Ringer in 1883 drew attention to the effect of the

different cations on the heart beat and

Hook~r

(1929)

suggested that potassium inhibition induced by an excess of
potassium chloride could be used to stop the heart when its
beat was disorganized by ventricular fibrillation.

He

recommended a solution of calcium chloride as an antidote to
potassium when re-starting the heart.

This work was revived

b;y Montgomer;y et al. (1954) in o:rder to reverse ventricular
fibrillation in hypothermic patients.
Senning (1952) attempted to inhibit cardiac contractions temporarily by the injection of acetylcholine, methacholine and potassium chloride, but he was apparently
unsuccess!Ul because he maintained coronary perfusion which
immediately washed out or diluted the cardioplegic agent.

4
Based on these observations, Melrose et al. (1955)
succeeded in evolving a method of stopping and re-starting
the heart at both normal and reduced body temperatures.
Thirty-three adult dogs were used to determine whether the
induction of cardiac arrest by chemical means was a practical measure.

While the vital centers were protected with

the heart-lung machine or by reduction of the general body
temperature, cardiac arrest was induced by an injection of
potassium citrate into the root of the aorta.

The arrest

was maintained as long as an adequate level of potassium
citrate remained in the coronary arteries.

Normal beat was

restored when simple pertusion of the coronary circulation
reduced the level of potassium citrate.

This technique

provided an almost bloodless operative field with excellent
visibility.

The heart is completely motionless and flaccid

so that it can be manipulated for the exact placing of
sutures.
Following the work of Melrose et al. a great deal of
interest was aroused in this field.

~aker

and Dreyer (1956)

were able to induce cardiac arrest by potassium citrate and
demonstrated the restoration of the normal beat by simple
per:f"usion.
Previous experiments left unanswered the degree of
asphyxia to be expected following cessation of coronary
circulation during induced cardiac arrest.

To investigate

this problem, Bentall and Melrose (1957) studied the production of lactic acid after varying periods of arrest, in

5
the isolated per!Used hearts.

The lactic acid concentration

in the effluent per.fu.sate rose af'ter interruption of per.fu.sion.

The concentration increased progressively as the

interruption was prolonged.
Elective cardiac arrest with potassium citrate has been
applied clinically by different workers employing the Melrose
technique.

Effler et al. (1956) successf'u.lly treated two of

three cases of congenital heart disease with the heart resuming normal sinus rhythm in all three cases.

In 1957,

these same investigators observed that ventricular asystole
occurred frequently with other clinical cases.
Kolff

~ al

(1957) reported that, in all of the

thirty-seven cases in which the Melrose technique was
applied, complete ventricular asystole was achieved and it
was possible to restore effective heart action and adequate
circulation.

Ventricular fibrillation occurred in seven

patients, but normal rhythm always returned.

It was found

that under the conditions of the experiment the heart could
resume its normal action after periods of arrest as long as
4.0 minutes.
In a series of experiments on dogs, Helmworth and
co-workers (1958, 1958a, 1959), found that no animals died
following 30 minutes of total cardiopulmonary by-pass,
whereas animals in which potassium citrate arrest was induced
for 30 minutes had a mortality of nearly fifty per cent
with evidence of some myocardial

dam~ge.

6
At the same time other investigators were using acetylcholine as a cardioplegic agent.

Moulder et al. (1956) re-

ported on the use of acetylcholine to inhibit cardiac
contractions in dogs and humans under hypothermia.

Lam et

al. (1957, 1957a, 1958) reported clinical experiences with
acetylcholine-induced cardiac arrest during intracardial
surgical procedures.

They found rapid resuscitation and low

incidence of ventricular fibrillation during recovery.

It

was of interest to note that during acetylcholine-induced
caiadiac arrest the heart might beat if the ventricle was
stimulated mechanically.
Sergeant et al. (1957) showed acetylcholine to be a
safe and effective agent for both the hypothe:rmic and the
normothermic dog heartso

Similar success was obtained in

eight human open-heart operations.
Other investigators have attained less success with
acetyleholine as a cardioplegic agent.

Shramel et al. (1957)

could produce cardiac arrest with acetylcholine and methacholine for only short periods of time with no complete
cessation of electrical activity during any of the arrests.
Kenyon et al. (1960) and McKain (1961) reported failure to
produce cardiac arrest with acetylcholine.

Bramwald et al.

(1959) found severe depression of myocardial activity after
20 to 30 minutes arrest with either acetyleholine -or potassium citrate.
Meanwhile, Bigelow et al. (1950, 1950a) and Swan $lid

7
Zeavin (1954) had shown that hypothermia protected the heart
from long periods or oxygen deprivation by decreasing its
metabolic requirements.

This fact stimulated its use as a

method for inducing cardiac arrest.

Various combinations or

chemically induced arrest in conjunction with hypothermia
have been reported in the literatureo

In a series or reports,

Cooper et al. (1959) and Willman et alo (1959, 1959a}, have
shown marked depression of left ventricular myocardial
function atter a 30-minute arrest with either potassium
citrate or acetylcholine.

Partial protection or the heart

was provided by previously cooling to 28°0.

Weirich et al.

(1959) had noted a similar effect on myocardial f'u.n.ction
with increasing deterioration as the period or arrest wa•
prolonged from 5 to 20 minutes.

McKain (1961) and Berne

(1958) could not maintain cardioplegia with acetylcholine
even under hypothermic conditions.
McFarland et al. {1960) rep orted myocardial necrosis
in 79 per cent or the patients subjected to potassium citrate arrest who had died at various intervals following
open-cardiac operations.

The lesion was not observed on

the hearts or patients who underwent similar procedures
without arrest or with ano.xic arrest.
Kenyon et al. (1959) admini stered potassium citrate
and acetylcholine with the in:!'usate temperature at
Cardiac arrest occurred in only

4

4°

or 5°Co

per cent or the animals

treated with acetylcholine in comparison to 100 per cent ot

8
those injected with potassium citrateo
An indication that, with potassium citrate arrest,

the ATP, phosphocreatine, and glycogen levels fell much more
rapidly than with selective cardiac hypothermia was first
presented by Gott et al. (1959).

These results have been

cont'irmed by Hall et al. (1959) and Ellison et al. (1960)0
According to these workers hypothermia appeared to be
superior to arrest by potassium citrate for the maintenanae
of the myocardial energy sources.

-

Kusinoki et alo (1960), have carried out an investi-

-

gation on cardioplegic agents in both the normothe:rmic and
the hypothermic state.

They concluded that cardiac arrest

for fifteen minutes by eny of the techniques studied resulted in depression of myocardial !'unction to 50-70 per cent
of the control function when measured 15 minutes post-arrest.
HY.Pothermia to

25°c partially protected the heart rendered

hypoxic for 15 minutes; and, in comparison with other
methods studied, cardioplegia by this technique resulted in
least depression and best recovery of myocardial function.
Several other chemical agents or combinations of
these and other methods for inducing cardioplegia have been
reported.

Merrit et al. (1958) had reported that magnesium

by itself was not a satisfactory cardioplegic agent.

How-

ever, he pointed out that potassium and magnesium ions appeared to act synerg!sticallyo
Young et al. {1956) utilized a combination of magnesium

9
sulfate, potassium citrate and neostigmine methylsulfate to
induce cardioplegia.

The effects obtained were apparently

superior to potassium citrate alone in terms of post-arrest
recoveries.

Similar results were obtained by Sealy et al.

(1958) and MiJn.es et al. (1958).
Mondini et al. (1957)s demonstrated that isolated
guinea pig hearts were arrested in diastole for 3 to 5
minutes with a combination of acetylcholine and procaine
hydrochloride.
Clark

~

al. (1959) devised a method for inducing

cardiac arrest by passing blood through a selectively
charged magnesium ion exchange resin.

The resulting hypo-

calcemic blood was then perfused into the coronary system
producing arrest.

Recoveries a.f'ter forty-five minutes were

obtained with no gross evidence of damage.
Yashar et al. (1960) subjected thirty dogs to
cardiopulmonary by-pass and cardiac arrest was achieved by
means of various cardioplegic agents.

They observed that

cardiac arrest could be achieved with sodium citrate, sodium
phytate, methacholine, and potassium chloride, in addition
to potassium citrate and acetylcholine.

The rate of re-

covery after cardiac arrest and perf'usion of the coronary
arteries with arterialized blood was not predictable.

There

was no relationship between the dose injected and the duration of the cardiac arrest or the rate of recovery.

None

of the agents tested appeared safe for routine clinical use.

10

Advances in the correction of stenotic and insufficient
aortic valves have prompted the use of a retrograde pertusion
technique in order to facilitate the direct vision of the
diseased valveo
~

This technique has been employed by Gott

alo (1959), Lillehei et al. (1958)j and other investiga-

torso
In recent years it appears that hypothermia is
favored over all other methods used to arrest the heart as
an adjunct in open heart surgeryo
Reports of adverse effects of prolonged elective
cardiac arrest upon myocardial structure and .function led
Miller et alo (1961) to undertake a comparative study of
methods of arrest.

Arrest was achieved by potassium cit-

rate, anoxia, and a combination Gf anoxia and local hypothermia.

The changes produced in the heart function follow-

ing arrest by potassium citrate were less than those
observed in other groups.

Extensive myocardial necrosis

was observed following one hour of potassium citrate arrest.
Again in 1964 9 these investigators studied the progression
or reversibility of acute changes in myocardial .function and
structure a.fter periods of elective cardiac arrest from 30
to 60 minutes.

'fhey found that cardiac .function was

variably impaired following the arrest period.

Gross and

microscopic areas of necrosis were observed in dog hearts
following recovery from potassium citrate arrest.

No

morphological changes were observed following cardiac arrest

...

··

,

11
by hypothermia with or without coronary perfusion.
Bjork and

For~

(1961) performed an experimental study

on dogs to compare the different methods of inducing cardiac
The arrest was maintained for 30 to 40 minutes.

arrest.

Little alteration in the myocardium was found after hypothermic and acetylcholine arrest whereas the moat pronounced
changes were found after potassium. arrest .

They concluded

that deep hypothermia was preferred over the other methods
because of the diminished oxygen demands during this type of
arrest.
Brewer et al. (1963) upon evaluating cardioplegics in
patients undergoing open hes.rt surgery 9 found h;rpothermic
arrest to be superioro

The mort ality following this type of

arrest was lower than with any of the others and myocardial
degeneration was less severe in the hearts of the patients
that diedo
Redo (1962) evaluated the effects of prolonged periods
of cardioplegia on the mechanical and electrical activity or
the isolated guinea pig heart.

Arrest was achieved using

potassium citrate 9 Sealy 1 s mixture, acetylcholine, anoxia
and hypothermia.

Arrest up to periods of 60 minutes by the

use of potassium citrate, Sealyus mixt ure 9 or potassium
citrate were followed by mechanical recovery of 83 to 100
per cent.

Anox.ic arrest led to the poorest return of cardiac

action as compared with the other methods used.
indicated that the l onger the d1J.11.Jt"ation

or

The results

arrest, the longer

12
the heart takes to recover and the poorer is the mechanical
recovery.

Fibrillation occurred in all instances a:tter pro-

longed periods of cardioplegia except when the arrest was
achieved by hypothermiao

Fibrillation reverted to normal

rhythm spontaneously within several minutes.
Burdette and Al Sha.mm.a {1962) reported a decrease in
myocardial ATP and concomitant increase in ADP and AMP
during normothermic hypoxic or potassium citrate arrest.
Hypothermia did not prevent the metabolic change$ but
appeared to facilitate

rec~veryo

More recently 9 Berne et al. (1964) were unable to
show any significant differences between the potassium citrate arrest and the hypothermic arrest.

These findings are

in contrast to those reported by Gott et al. (1959) 6 Hall
et ale (1959) 9 and Ellison et al. (1960).
From various reports in the literature it appears
that certain structural substitutions in the cyclohexanol
ring can bring about ca!"dioplegic properties.
Nelson et .!!!· {1958) reported that in certain preliminary experiments trans-2-.Q.-tolylcyclohexanol had been
able to arrest the heart of a dog but recovery was not
success.fulo
Huitric (1959) published a note concerning the production of reversible mechanical arrest on isolated cat
heart with this sa:me compound.

This prompted Huitric to

synthesize a series of cyclohexa:nol derivativeso

13
Smookler and DeFeo (1962) extensively investigated
cyclohexanol and certain of its 2-tolyl and 2-chlorophenyl
substitution products for cardioplegic effectso

The compounds

were found to be capable of lowering the blood pressure of
intact rats and depressing myocardial contractility of
isolated guinea pi.g hearts o

The inhibitory effects varied

from slight depression to complete arrest.

Evaluation of

potency was based on the ability to produce cardiac arrest
and the duration of the arresto

In both series of substi-

tutions the trans-2-Q.-tolyl derivatives were the most potent
and the cis derivatives the least potento

Mechanism studies

indicated an antagonism between these compounds and calcium.

In unpublished work 9 Smookler (1961) showed that
trans-2-.Q.-tolylcyclohexanol 9

tran~-2-Q-chlorophenylcyclo

hexanol and cyclohexanol were capable of inducing cardiac
arrest in dogs undergoing
appeared to be no

cardi~pulmonary by-pas~o

relatio~hip

There

between the dose employed

and the production of cardiac arresto

Recovery was faster

and more consistent with trans-2-Q-tolylcyclohexanol.
Unpublished work by Smith (1963) showed that other
derivatives of cyclohexanol produced similar effects in the
cardiovascular systemo

The compounds teated were trans-2-.Q.-

tolyl, cis-2-.Q.-tolyl 9 tranai-2-Q-t ·Dilyl 9 and cis-2-Q-tolyl
derivatives of cyclohexylamine hydrochloride and other miscellaneous cyclohexane derivatives.

Trans-2-o-tolylcyclo-

hexylamine hydrochloride was the moat potent of the cyclohexylamine series testeda

~

Other derivatives of cyclohexanol and cyclohexylamine
were evaluated similarlyo

Unpublished work by Kosegarten

(1966) showed that the non-ethy.nyl cyclohexanol derivatives
were more potent in producing a hypotensive response than
were the derivatives of cyclohexylaminea

£.!!. -

Trans-2-Q.-tolyl-

1 9 4-cyclohexanediol and trmJJ.~-2~Q.-tolyl-tran~-lD5-

cyclohexanediol were equally effective and the most active.
Converselyj the cyclohexylamines were more potent cardioplegic agentso

An antagonistic effect between calcium and

the negative inotropic action of these compounds was demonstrated on isolated rat atria.
Based on these reportsj there appears to be justification in assessing the comparative cardioplegic effects
of other cyclohexanol derivativeso

III.

~

INVESTIGATION

!• Objectives
It is evident from recent reports in the literature
that certain substituted cyclohexanols show cardioplegie
prctperties.

Smookler and DeFeo (1962) repol'tad that certain

cyclohex1µ1ol derivatives in a series synthesized by
Huit~ic

were also capable of producing cardiac arrest.

Similar results were obtained by Smith (1963) with substitru.ted cyclohex7laminea and miscellaneous cyclohexan.Bl
derivatives.

Since that time Huitric has synthesized another

group of cyclohexanol derivatives.
This investigation was undertaken to determine the
comparative effects of these substitution products on the
cardiGvascular system and to attempt to relate the various
ef.f'&cts of the compounds to their molecular stl"tlctures.
The objectives of the investigation were as follows:
1.

~o

screen pharmacologically the various compounds

.for their e.f'f'ecta on the animals or tissues used.
2.

To attempt to determine the mechanism through

which the compounds' effects are brought about.
~.

!he Cpmpounds

The substituted cyclohexanols used in this investigation (Figure 1) were synthesized by Dr. Alain C. Huitric of
the Department of Pharmaceutical Chemistry, University of
Washington, College of Pharmacy, Seattle, Washington.

Since
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Figure lo

Cyclohexanol Derivatives

rl_b

~\fS/
R2

Nmne

-OH

methyl 3-hydroxy-2-.Q.-tolylc yclohexylac etate
(SH-24)
methyl 3-acetoxy-2-.Q.tolylcyclohexylacetate
(SH-26)

-CH J-0-CH
2

'

3-hydroxy-2-.Q.-tolyloyclohexylacetic acid
(SH-23)

-OH

>=O

trans-3-oxo-2-.Q..-tolylcyclohexylacetic acid

(SH-16)

)< . . . . ._
0

H

0-CH~H-CHzOH
~

keta.l or glycerel and 2-otolylc yclohexanone
-

(#5)

CH

I 3
2-.Q..-tolylcyclohexen-2-one
( SH-ll~_)
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the solubility of the compounds was not reported by Dr.
Huitric, the water solubilities were determined according
to the

~ollowing

procedure:

25 mg of the compound was weighed into a vial

Ten to

on a Mettler analytical balance.
dropwise from a pipette.
thoroughly agitated.

Deionized water was added

After each addition the vial was

It was found necessary in all oases

to employ heat to effect the solution.

The procedure was

repeated three times for each compound, and the average of
the three determinations was taken as the solubility.
the compound had dissolved, it remained in

sol~tion

Once

for at

least several hours.
Some of the compounds were practically insoluble in
water.

The water solubilities of these compounds. were not

determined.

They were dissolved in a mixture of polyethylene

glycol (400) and water.

Table I lists the physical state of

the compounds and the water solubilities.
C. Animals Used
Rats--Albino rats of the Wistar (MW-2) strain were
employed for all the rat experiments.
Guinea pigs--The guinea pigs used were of a heterogeneous group.
Rabbits--All rabbits were albino.
D. Experimental Procedures and Results
This investigation was divided into four sections:
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1.

The effects of the compounds on the blood pressure of
intact anesthetized rats.

2.

The effects of the compo'Ull.ds on isolated guinea pig
hearts.

3.

The effects of the compounds on isolated rat atria.

4.

~he

effects of the compounds on rabbit intestinal smooth

muscle.
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TABLE I
Physical state and water solubility of various
derivatives of cyclohexanol.

Compound
methyl 3-hydroxy-2-.Q_-tolylc yclohexylacetate
(SH'-24)
trans-3-oxo-2-.Q_-tolylcyclohexylacetic acid

(SH-16)

Physical
State
solid

solid

3-hydroxy-2-.Q..-tolylcyclohexylacetic acid
(SH-23)

solid

methyl 3-acetoxy-2-.Q..-tolylcyclohexylacetate
(SH-26)

solid

2-.Q_-tol1lcyclohexen- 2-one

solid

ketal of glycerol and 2-otolylcyclohexan.one

liquid

(SH-14)

Water

Solubility
(mg /ml.)
6.3
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1.

Effects of Various Derivatives of Cyclohexanol .Q.B the

Blood PI"el!sure of Ra.ts
A·

Experimental Procedures
Wister rats of either sex weighing approximately

200 g were anesthetized by an intraperitoneal injection
of l.2g/kg of u:rethan and
ventral side upo

~ecured

to an animal board,

A midline incision was made into the

neck, and the trachea was ca.nnulated to
respirationo

in~ure

freedom of

The right carotid artery was isolated and

eannulated with a fine glass cannula connected to a U-tube
mercury manometer via polyethylene and rubber tubingo
The entire system was filled with normal saline
(0.9~

NaCl) an.d the pressure in the system was increased to

approximately 90 mm Hg to prevent undue loss of the
blood into the saline bridgeo

animal~s

To prevent clotting a solution

of Ool ml of heparin sodium was added to the cannula prior
to

cannulati~no

of a glass

The blood pressure was recorded by means

capillar~

float from the manometer onto the smoked

paper of a slowly moving kymograph.
simultaneou~ly

The time was recorded

with the blood pressure.

The blood pressure

was allowed t o s t abilize for a period of 30 minutes prior
to administration of any of the experimental compounds.

The compounds were adll'.l.inistered intravenously in either
femoral veino

The various injections were carried out at
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intel'"Val.s which allowed ret'\lU>n ef the blood praasuPe to a
stead7

The

~tate lev~lo

t~t91

number of

injecti~ns

did not

exceed four per e.xperiment"

Dt')sage was adjusted acco:t'ding

to the results obtainedo

o~der

c~mp~und

a particular

or

pres&lU"'e

In

that would produce a drop in

approximat~ly

50

the response obtained were
computation~

In

to detel'mine the dose

pe~

cent 9 the

$Ubjec~ed

do~e

~t

bl~od

used and
regre~sion

to linear

earl"i.ad out b7 the IBM 1410 computero

the~e e.xpel"iment~

c7clohexylacetate and

acid were

te~ted 9

practical

pu:rpose~g

~nly

tran~-J~oxo-2-.2,-tolycyclohexylacetic

5ince the

employed for their

methyl 3-hydroxy-2-_2.=tolyl-

othe~

compounds were, tor all

insoluble in water and the solvent
admini~tration

interfered with their

response o

The activity of' the

<H.~mpoim.dB

was evaluated

a~

t'ollows:

lo

The

pe~

cent change from the norimal b1ood

duced by the

compotm.d~o

2..

!he dltil"'atitm. oif' the

).

2.'he dose of the
cb>~p

b.,

Effect~

A

compound~

et.feet.

needed to

p~oduce

a

50

p~l"

cent

blo~d p~e~~lU'~.

re~ult~

of the

(Table~

2o

h;rptl!t~:wiive

Result~

'!he
lo

in

pre~su~e p~~~

include the f'ollow:ing8
comp©und~

~n

the blood preS$Ure of rats

II an.d III).

co:mpa:f'i~on

of' the

compound~

tested on the blood

o:r rats (if able IV and Figwt"ei 2) ..

p:re5~Ul"e

22

TJtBLE II
E.ffect:s of methyl 3-·hyd:rr•c:K:y-2-.Q.~tolylcyclohe.xyla.cei·tililt'!f
(SH-24.) on the blood pressure of rat2u

Dose
'(mg/Kg}

NU.."llb e: r

Mean '/, Droop

of

in Blood

Trial~

PI"s~~rure

't S oDo

Dura.ti.on o.t" Drop
in Blood Pz·a~~ure
(Mean and Range)

(aec)

41 (J0-50)

2

4

4

3

8

4

42.3 (250=600)

12

3

1020 (900-1140)

16

4

1195 (1000-1!.i.J..i.o)

18

3

920 (860=1000 )

- - -· - --------

TABLE III
Ef'fec~t~

Do~e

(mg/Kg)

ot' tJr"an~-3=oxo~2-Q.-ttlllylcyclohexylacetlc
(SH-lbJon the bltir,id pressure of' rai;~o

Number
of·
Trial~

Mean% Drop

in Blood
Pressure

°!'

~LD o

4

4

17 ± 6

8

2

36 +- Oo7

10

3

40 +- 4oO

12

Ji

48 t

15

,,.,
:;i

5E5 +- 800

18

2

78 +- 2.0

~ldd

DuX<>a:t.i on o:f.' D;;r:•op

i.n BlfJod

F1"9~1:rtU'"e

(Me an and Raz.i.ge1 )
( ~e(;;)

187 {100-.300)

9o0

·----

·--------

.

~~-~--

TABLE IV
A comparison o.f the ED50 (hypotensive) of the cyclohexanol
derivatives tested on the blood pressure 8 •

Compou..nd

methyl 3-hydroxy-2-..Q.~
tolylc;yclohexylacetate

(SH-24)

trans-3-oxo-2-~-tolyl

cyclohexylacetic acid

(SH-16)

•rota.l
Trials

Calculated

ED5 0b

mg/kg

21

11~2

17

11.0

asee Figure 2.
hnerived f'rom the regression line f ormula ob"tained
.from the analysis of' results on the IBM 1410 Computer~

0

..

~ ~...

-20
CJ
1.

~

i:s

co

0)
~
~

~40

11.

'O
0
0

Ii:!
~

·~

«>60

<J
~

-80

1.3

Figure 2.

1.6
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2.2
Lag of Dose (mg/Kg x 10)

2.5

A comparison of the blood pressure effects produced by the
@yclo~xanol derivatives tested.

2.

The Effects of Various Cyclohexanol Derivatives .2!!. the

Isolated Guinea Pig Heart
A•

Experimental Procedures
Guinea pigs of either sex were sacrificed by cervical

dislocation.

'!'he thoracic cavity was opened and the aorta

was clamped.

The heart was removed and transferred to a

container of oxygenated per.fusion solution.

The aorta

was immediately ca:nnulated via an incision made in the
ventral surface.

A few milliliters of warm perfusion

solution was forced into the cannula to remove residual
blood from the coronary vessels and to determine whether
the tip of the cannula was occluding the coronary vessels.
The excised cannulated heart was quickly suspended
in an Anderson-Craver Apparatusl for the continuous per.fusion
of the heart.

Chenoweth 1 s solution (1946) as modified by

Smookler and DeFeo (1962) was used as the perfusion fluid.
The composition of the perfusion solution expressed in grams
per liter is as follows:
g/l
sodium chloride

7.00

potassium chloride

0.42

calcium chloride

0.24

magnesium sulfate

0.52

dextrose

1.80

sodium bicarbonate

2.10

1Metro Industries, Long Island City, New York.
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Three liters of stock solution containing 350 g sodium
chloride, 21 g potassium chloride, 12 g calcium chloride,
and 26 g magnesium sulfate were prepared and stored at
room temperature.

The final perfusion solution was pre-

pared the day of the experiment by taking 120 ml of the
stock solution, 3.6 g of dextrose, and 4.2 g of sodium
bicarbonate and diluting to 2 1 of solutiono
A mixture of oxygen (95%) and carbon dioxide (5~)
was bubbled continuously through the solution in the
reservoir bottle.

A constant temperature of 37o5°c was

maintained throughout the experiment.

The effluent fluid

was recirculated during the experiment, except after the
injection of the drug when at least 40 ml was withdrawn
to insure complete removal of the drugo
After the preparation had equilibrated, any remaining extraneous tissue was removed and a stainless steel
hook was inserted through the apex of the heart.

The

amplitude of contractions of the heart was recorded on a
standard kymograph by passing a thread from the hook to the
recording lever via a pulley system.
Injections were made via an injection spiral connected
to the perfusion canal.

Since the calculated volume of the

spiral was 1.5 ml, this same amount of the perfusion solution was injected in the same manner after each injection,
to insure complete administration of the drug.
The number of injections performed in each preparation

28
depended on the ability of the heart to recover from a previous dose and was always limited to five trialso
compound was tested in each experiment.

95

Only one

A depression of

per cent or more was considered to be cardiac arrest.
When testing the compounds soluble in a mixture of

polyethylene glycol and water, an equivalent amount of the
solvent was employed as a control, prior to each injection,
in order to determine its effects.
The dose and response were subjected to linear regression computations carried out by the IBM 1410 computer.
The dose producing

50

per cent negative inotropic response

was calculated from a graph.
The activity of the compounds was evaluated as
f'ollows:
1.

The incidence of cardiac arrest at a particular

dose, and the duration of arrest at that dose.
2.

The incidence and per cent of cardiac depression,

it no arrest occurred.

3.

The time to return to

50

per cent of the normal

contractions.
b.

Results
The results include the following:

1.

i'b.e effects of the various cyclohexanol derivatives on
the isolated guinea pig hearts (Tables V to X).

2.

A comparison of the effects of the various compounds on
the isolated guinea pig hearts (Table XI and Figure 3).

TABLE V
Effects of methyl 3-hydroxy-2-o-tolylcyclohexylacetate
(SH-24) on the isolated guinea pig hearto

Dose
(mg)

Cardiac Arrest
Arrest/Trial

Duration of
Arrest
(sec)

Mean 3 Depression
+ S.D.
(if no arrest)

-

of 503
Return
Mean and Range
Time

(sec)

o.s

0/3

34 + 2

55 (50-60)

1.0

0/3

57 + 1

85 (80-94)

1.5

0/3

78 + 12

126 (100-150)

2.0

2/3

89 + 5

297 (180-430)

-

200 (120-280)

TABLE VI

Effects of trans-3-oxo-2~o-tolylcyclohexylaeetic acid
(SH=l6) on th~ isolated guinea pig hearto

Dose
(mg)

Cardiac Arrest
Arrest/Trial

Duration of
Arrest
(sec)

Mean 3 Depression
(if no arr~st)
!" So Do

Time of 503

Return
(Mean and range)
(sec)

OoS

0/2

18 + 2

100 (80=120)

0.75

0/2

38 + 4

130 (110=150)

loO

0/2

53 + 4

490 (480-500)

2o0

0/3

82 -+ 7

217 (190=250)

2o5

2/2

~

78 (70=85)

220 (200=240)

TABLE VII
Effects of methyl 3-acetoxy-2-o=tolyleyclohexylac~tate
(SH-26) on the isolated~guinea pig heart.

Dose
(mg)

Cardiac Arrest
Arrest/Trial

Duration of
ArreBt
(sec)

Mean

3 Depression

+ L)C)o
"'D

=-

I)

(sec)

(if no arrest)

~

Time of 503
Return
(Mean and range)
(sec)

0/2

35

4

110 (100-120)

0.10

0/2

39 ~ 5

170 (150 190)

0.25

1/4

150

2/2

125 (120-130)

85

.!

8

00

427

(320~500)

285 (270-300)

TABLE VIII

Effe©ts of 2-o~tolylcyclohexen = 2=one (SH=l4)
on the I'solated guinea pig heart~

Dos~

(mg}

Cal'diac Arr~st
Al' rest/Trial

Duration of
Arr~st

(sec)
( Mea~

and range)

Mean 3 Depr@ssion
( if no arr@ s t )

=SoDo

Tim~

of 503

R.etu:t>n

(Mean and range )
(s~(l)

0/3

26 + 3

87 (70-110)

0/3

28 .t 3

92 (80=105 )

0/3

57 =+ 2

133 (125-150)

92 + 6

212 (150-320)

2/4

=

137 (130=145)

~

·TABLE IX

Effects of l-hydroxy-2-o-tolylcyclohexylacetic acid (SH-23)
on the isolated guinea pig heart.

Dose
(mg)

Cardiao Arrest
Arrest/Trial

Duration of
Arrest
(Mean and range)

Mean 3 Depression
(if no arrest)
!' s. D.

Time of 501

Return
(Maan and. range)

2.S

0/2

10 + 7

9 (7-11)

s.o

0/2

12 + 8

-

9 (6-12)

6.0

0/2

8 + 3

-

12 (11-13)

7. ()

0/2

23 -+ 11

18 (16-20)

8.0

0/2

30 + 13

24 (21-27)

-

TABLE X
Effects of ketal of glycerQll and 2=o=tolylcyiclohexanone
on the isolated guinea pig heart.

Dos®
(mg)

Cardiac Arrest
Arrest/Trial

Duration of
Arrest
(sec)

(Mean and range)

Mean 3 Depression
!: S.D.

(if no arrest)

Time of 503
Return
(M~an and range)
(sec)

0/3

29 + 7

77 (46=104)

0/2

57 + 3

105 (90-120)

1/3
3/3

65

73 (40-100)

78

!

3

305 (180=330)
110 (100-120)
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TABLE XI
A comparison of the ED
of the
95 (cardio-inhibitory)
cyclohexanol derivatives
on the isolated
guinea pig hearta.

Compound

Total
Trials

methyl 3-hydroxy-2-2-tolylcyclohexylacetate (SH- 24)

12

trans-J-oxo-2-.Q.-tolylcyclo-:,
hexylacetic acid (SH-16) , -~
·-

11

2-o-to~1lcyclohexen-2-one

2.11

13

3.89

methyl 3-acetoxy-2-.Q_-tolylcyclohexylacetate (SH-26)

10

4.17

ketal of glycerol and
2-..2_-tolylcyclohexanone

11

5.52

3-hydroxy-2-Q_-tolylcyclohexylacetic acid (SH-23)

10

TsH-14)

c

asee Figure 3.
bnerived from the regression line formula which was
obtai.ned from the analysis of results on the IBM 1410 Computer.
c

Compound did not produce more than 30 per cent depression in the dosage range tested.
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E.ff'ecta of' Various Cyclohexanol Derivatives

fill.~

Isolated Rat Atria
a.

Experimental Procedure
Albino rats, either male or female, were sacrificed

by cervical dislocation.

The thoracic cavity was opened by

removal of the sternum and the heart
and immersed in
solution.

was

rapidly removed

a container filled with warm oxygenated

After 20 to 30 minutes the atria were freed of

ventricular muscle, fat, and connective tissue and suspended
in a tissue bath containing the same nutrient solution as
used in the per.fusion experiments.
The temperature of the bath was maintained at 32°c
as suggested by Webb (1950) in order to reduce the rate and
increase the amplitude or contractions.

The solution in

the bath was continuously aerated with a mixture of oxygen

(95%) and carbon dioxide (5%).
The tip of the right atrium was then attached to a
stainless steel hook attached to a recording lever with a
thread.

A second hook attached to a removable glass oxygen

bubbler in the organ bath was then inserted to the left
atrial appendage.

The lever was adjusted for maximum

magnification of contractions.

The amplitude of contractions

and the rate of spontaneous contractions were recorded on a
slowly moving kymograph.

In order to obtain a constant

amplitude of contraction the atrial preparation was kept in
the bath .for at least 30 minutes before starting the experiment.
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Methyl 3-acetoxy-2-.Q..-tolylcyclohexylacetate was selected for
mechanism studies on the isolated rat atria.

A

4

per cent

solution of calcium chloride was used to determine the
possible interactions with the compound.

All compounds

were allowed to act for 3 minutes before washing or adding
other agents.
The activity of the compounds was evaluated as
follows:
1.

The per cent change in the amplitude of con-

t .r action.
2.
b.

The· change in the rate of the preparation.

Results
The results include the followingi

1.

The effects of the various cyclohexanol derivatives on
the isolated rat atria (Tables XII to XVI).

2.

A comparison of the effects of the variou.s compounds on
the isolated rat atria (Table XVII and Figure

4).

J. Calcium chloride (4.0 mg) produced an increase in the
amplitude of contraction of approximately 80 per cent
at the end of 3 minutes.

Over the period of 3

minutes, the rate of contraction increased.

4.

A dose of 0.75 mg of the compound reduced the amplitude
of contraction by approximately 50 per cent within 1
minute, with no apparent change in rate.
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5.

When methyl 3-aoetoxr-2-.Q.-tolylcyclohexylacetate had
reduced the amplitude ot contraction by
it was round that it required

4.0

4

50

per oent

successive doses or

mg ot calcium chloride each to restore the

amplitude ot contraction to a normal levelo

When

16 mg was administered at one time there was complete
rec.ovary within 3 mi.n utes.

TABLE XII
Effects of' methyl 3-hydroxy-2-.Q.-tolylcyclohexylacetate
(SH-24) on the isolated rat atriao

Dose
(mg)

Number
of
Trials

'fo Depression
± S.,D.

'fo Change in
Rate
(Mean & Range)

1.0

3

25 + 8

7 (4-10)

1.5

3

31 ± 2

5 (1-11)

2.0

3

56 +- 12

7 (4-10)

3.0

3

31 +- 6

8 (6-10)

4.0

3

46 +- 9

12 (5-22)
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TABLE XIII
Effects of methyl 3-acetoxy-2-.Q.-tolylcyclohexyl
acetate (SH-26) on the isolated rat atria.

Dose
(mg)

Number
of'

Trials

'/o Depression
:! S.D.

fo Change in
rate
(Mean & Range)

Oo25

3

15

!

2

11 (9-14)

Oa50

2

31

!

11

13 (12-14)

0.75

2

51

!

11

8 (4-11)

1.00

3

55 '! 5

26 (23-29)

2o00

3

44

13 (10-15)

'!" 11
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TABLE XIV
Efrects of 2-Q.-tolylcyclohexen-2-one (SH-14)
on the isolated rat atriaa

Dose

Number

o:r

%Depression

% Change

in

rate

(mg)

Trials

± S .. D.

1.0

3

25 +- 15

1.5

3

34 '!'

8

15 (7-22)

3.0

5

46 "!'

6

22 (19-24)

4.5

2

72 +

2

37 (33-41)

(Mean & Range)

6 (3-10)
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Effect$

~f

the ketal of glycerol and 2~.Q.-tolylcyclohexanone
(#5) on the isolated rat atriao

N'tlmber
of'

%Depres$ion
'!' SoDo

11

T:t ial~

0.73

3

23 '!' 13

1.45

3

49

2.92

2

69 ~ l

5.80

13 ( 9-16)

~ 6

75.3 '!'

Change in Rate

(Mean an~ Range)

1
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TABLE XVI
Effects of tr~a-3-oxo -2-Q- tolylcycl ~hexylacetic
acid {SH=i6) on the i~~lated rat atriao

Do~e

{mg)

Nuimber

% Chmge

or

in Rate

Trials

3
2
2

35 "!'

1

5 (2-8)
7 ( 0-7>
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TABLE XVII
A comparison of the ED~ 0 of the c7clohexanol
derivatives ~ested on the
isolated rat atriaoa

NW11ber
Compc~d

3-h7drox7-2-.2_-tol7loyolohex7lacetate (SH-24)

met~11

ot
Trials

15

5o85

meth7l J-acetox7-2-a.tol7l0Jolohex7lacetate

14

1.38

ketal of gl7cerol and
2-.e,-tolyloyolohexanone

11

lo75

(SH-26

2-o-tot!lc7olohexen-2-one

TSR- . )

2.56

•see Figure 4.
'bnerived t:rrom the regrea1d.cn line .tormu.la obtained
from the anal7sis of the re1nlllts on the IBM 1410 Computero
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Figure 4.

.8

1.2

1.6

2.0

Log of Dose (mg x 10)

A comparison of the effects produced by the various cyclohexanol derivatives tested on the isolated rat atria.
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l!·

~Effects

ot

Various C:Yclohexanol Derivatives .Q.B the

Isolated Rabbit Ileum
Ja•

Experimental Procedures
In order to determine the effects on smooth muscle

some of' the compounds were tested on rabbit small intestine,
utilizing the Magnus batho

Rabbits of either sex were

deprived of food for a period of
experimento
location.

24

hours prior to the

The animals were sacrificed by cervical disThe small intestine was then removed from the

body and washed with warm Tyrode's solution to remove all
fecal matter.
2 cm

A small strip of the tissue (ileum), about

long, was suspended in a 70 ml

Magnus bath contain-

ing Tyrode's solution.
A mixture of 95% oxygen and

5% carbon dioxide was

continuously bubbled through the solution in the batho
The temperature of the solution was maintained at 38°c by
means of a constant temperature unit.

The spontaneous contractions of the ileum were recorded on a slowly moving kymograph drum.

After placing

the segment of ileum in the bath a period of about one half
hour was allowed before e:n.y drugs were injected.

These were

added directly to the muscle chamber with a syringe.
fresh piece of ile"Wl'l was employed for each drugo

A

The mixing

of the drugs in the bath was facilitated by the bubbles of
gas by which the bath was oxygenatedo

Following each dose,

fresh solution was added to the batho

If the tissue

48
recovered

sufficiently~

it was used for three trials before

replacing with a new stripo
'l'he response of the preparation wa.s measured aa
follows:
1.
the

The change in the amplitude of contraction of

ti~sue.

2o

The change in the rate o:f contraction of the

preparationo

3o
b.

The change in the tone of the tissuee

Results
The results include the followingi

1.

The effects of various cyclohexanol derivatives on the
isolated rabbit ileum (Tables XVIII to XXII)o

2o

A dose of Oo70 mcg

of acetylcholine established sub-

maxima.1 contractions of the intestinal strip within

seconds.
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When the ketal of glycerol and 2-o-tolylcyclo-

hexanone had reduced the amplitude of the
strip by approximately

50%

inte~tinal

at the end of 3 minutes,

it was found that the compound did not antagonize the
action of acetylcholineo
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TABLE XVIII
Effects of methyl 3-hydroxy-2-.Q.-tolylcyclohexylaoetate (SH-24) on the isolated rabbit ileumo

Dose
(mg)

1.00

1.48

2.00

~ Change in

~ Change

in Rate'a

'/, Change
in Tone.a

13

7

0

8

7

0

18

14

0

20

7

0

26

0

0

41

7

0

Amplitude&

&All values represent a decrease from normal values
expressed as 100 per cent.
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TABLE XIX
Effects of meth7l 3-acetoxy-2-.Q.-tolylcyclohexylacetate
(SH-26) on the isolated rabbit ileum.

Dose
(mg)

0.30

.......
0.50
0.87

1.74

'I> Ohange in
Amplitudea

'{. Change
in Ratea

'{. Change
in Tone•

0

0

8

9

0

12

8

0

11

4

0

9

17

0

3

.32

0

16

22

0

16

51

0

20

aAll values represent a decrease from normal values
expressed as 100 per cent.
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TABLE XX
Effects of 3-hydroxy-2-.Q.-tolylcyclohexylacetic
acid (SH-23) on the isolated rabbit ileum.

Dose
(mg)

2.0

3.0

4.0

'/, Change in
Amplitudea

'/, Change
in Ratea

~ Change

in Tonea

+ 9

+12

-3

0

0

-3

+10

0

-7

+10

0

-6

+ 4

+ 7

-1

+4

0

-3

aValues represent an increase (+} or decrease (-) as
compared to normal values expressed as 100 per cent.
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TABLE XXI
Effects of 2-Q.-tolylcyclohexen-2-one (SH-14)
on the isolated rabbit ileumo

.Dose
(mg)

3.0
6.0

9.0

'!>

Change in
Amplitudea

~Change

in Ratea

"' Change
in Tonea

9

0

70

15

6

48

13

0

22

16

7

45

30

6

47

aAll values represent a decrease from normal values
expressed as 100 per cento

..
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TABLE XXII
Effects of the ketal of glycerol end 2-.Q.-tolylcyclohexanone on the isolated rabbit ileum •

Dose

. ~ Change in

fo Change
in Tonaa

17.8

1.8

6.4

18.1

o.o

4.0

38.4

7.0

12.5

25.0

o.o

10.0

27.2

6.o

o.o

32.0

o.o

o.o

68.0

Q.0

10.0

74.0

17.0

13.0

71.0

J.4.o

8.o

74.0

o.o

7.0

77.0

o.o

1).0

77.0

o.o

2.0

82.0

o.o

2.0

Amplitudea

0.48

o.89

1.78

2.24
2.68

2.90

~Change

in Ratea

(mg)

100.0

100.0

aAll values represent a decrease from normal values
expressed as 100 per cent.

IVo

DISCUSSION

Previous reports in the literature have indicated
that several cyclohexanol derivatives can produce a hypotensive effect and possess cardio-inhibitory properties.
A preliminary investigation by Huitric et

a~.

(1959)

demonstrated that an intravenous injection of trans-2-,2.tolylcyclohexanol Rroduced a rapid hypotensive effect on
the intact dog.

A

r~versible

cardiac arrest was produced

~

without affecting

myocard~al

properties when this compound

was perfused through isolated cat hearts.

Pharmacological

evaluation studies by Smopkler and DeFeo (1962), Smith
(1963), and more recently by Kosegarten (1966) showed the
degree of cardio-inhibitory activity to be related to the
f'unctional groups and stereochemistry of these compoundso
In this investigation, a number of substituted cyclohexanol
compounds, synthesized by Huitric, were investigated for
their effects on the cardiovascular system in an effort to
~ther

determine their possible C&.r'dio-inhibitory activity

as related to moleculal" structure.
To determine the gross effects produced by these
compounds on the ca:rdiovascular system, studies were undertaken utilizing the blood pressure of rats.

Only two of the

compounds could be tested for hypotensive activityo

The

other compounds were not soluble in water and the solvent
system employed for these derivatives was found to possess
an effect of its own.

~he

compounds investigated were:
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methyl 3-hydroxy-2-.Q.-tolylcyclohexylacetate and
2-.Q.-tolylcyclohexylacetic acid.

trans-J~oxo-

The results demonstrate

that both compounds produce a rapid hypotensive activity upon
intravenous injection.

The duration of' action varied from a

few minutes to over 30 minutes.

The magnitude of the effect

appears to be somewhat proportional to the dose employed for
each compound.

It was observed that these compounds usually

produced some degree of' respiratory depression which paralleled the hypotensive response.

These findings confirm

those previously described by Smookler and DeFeo (1962),
Smith (1963), and Kosegarten (1966).
The comparison of the ED
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(hypotensive) indicates

that methyl 3-hydroxy-2-.Q_-tolylcyolohexylacetate (SH-24) and
trans-3-oxo-2-.Q.-tolylcyclohexylacetic acid (SH-16) were of
approximately equal potency.

The actual ED50 dose values

of these compounds dif'fered by only 0.20 mg with the former
exerting a slightly greater effect (Table IV).

Smookler ad

DeFeo have reported that substitution of a tolyl or chlorophenyl moiety in the number two position of the cyclohexanol
ring increases its hypotensive activity from 6 to 40 times.
It is evident that the f'ree acid (SH-16) and the methyl
ester (SH-24) show little difference in activity.

This

slight dif'ference could be attributed to the free movement
of the hydroxy group in the number 3 position in compound
SH-24 in comparison to the restriction on SH-16 due to the
presence of a double bond.

Because of the non-availability
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of the cis and trans isomers of the first compound and the
els isomer of the second compound 9 no correlation could be
made between spatial configuration and hypotensive effect.
All the compounds ware tested for their effects on
iaolated guinea pig heartso
solvent system employed for
ethylene glycol)

~howed

guinea pig

amplitude of

using the

of the compounds (Poly-

From Tables V to Xj it can be

dose levels employed on the isolated

t~e

heart~

s~me

injectio~

the solvent to produce a transient

positive inotropic effecto
seen that 9 at

Control

9

all the compounds tested depressed the

cont~actiona

of the isolated hearts and produced

complete arrest 9 with the exception of 3-hydroxy-2-.Q.-tolylcyclohexylacetic acido

With this compound only a 30 per cant

decrease in the amplitude of contractions of the isolated
heart was obtained in re5ponae to doses up to 800 mg.
Smookler and DeFeo (1962) reported that 8 of the 10
compounds tested on the isolated guinea pig hearts produced
cardiac arres'to

All the co:mpcnmds tested by Smith (1963)

produced cardiac arresto

Furthermore 9 all the compol.lll.ds

tested by Koaega.rten (1966) produced mechanical arrest 9
except

trans~2-.Q.-tolyl=cis-4-hydroxy-trans-5-hydroxycyclo

hexanolo

Thu~

9 our findings are in accord with those of

previous investigatorso
In this invastigation 9 on the

basi~

of the minimum

calculated effective dose to produce cardiac arreat 9 it
appears that methyl 3-hydroxy-2-.Q.-tolylcyclohexylacetate
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(SH-21~.)

and

trans-3-oxo~2-.Q.~tolylcyclohexylacetic

acid (SH-

16) were equally effective and the most potent (Table XI:).
The ED 95 (cardio=inhibi.tory) of these compounds differed
by Oo30 mg with the former exerting a slightly greater
effecto

However the duration of the arrest and the recovery

time were more prolonged with SH-24 than with the other
compound~

testedo

It will be recalled from the blood pres-

sure studies, that these amne compounds were also equally
potent in producing a hypOJtensive responseo

The keta.l of'

glycerol and 2-2-tolylcyclohexanone was the leaBt potent in
its cardio=inhibitory

From these findings it can

effect~o

be deduced that the presence of either a free hydroxy group
or other substituent in the n'\!m1ber 3 position is necessary
to elicit the desired pharmacological effecto
observed by previous workers in this fieldo
site,therefore 9 muat possees
stituent moietyo

It could

The receptor

area to fit with this sub-

~ome

aJ.~o

This has been

be said that the larger group

at the 3 position 9 the ketal of glycerol 9 must be producing
a

steric hindrance to the receptor sites, hence this com-

pound was the least active

or

tho~e

duration of action of the methyl

te~tedo

e~ter

The longer

(SH-24) is obviously

due to the blocking of the free ca.l"'boxylic acid grouping
necessary f'or conjugation.,
In the3e

experiment~

duration of cardiac

arre~t

9

in general 9 with regard to the

and to the per cent depression

in the amplitude of contraction 9 a

do~e-related

response to
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the compounds was foundo

None of the compounds showed signs

of cardiac toxicity, as indicated by the

recove~y

of the

hearts from the effects of the compounds following either
cardiac arrest or depresaiono
Studies on the isolated rat atria showed that the
compounds tested decreased the amplitude of contraction,
except trans-3-oxo-2-.Q.-tolylcyclohexylacetic acid (SH-16)
which produced a positive inotropic effecto
suf'ficient amount of this compound 9 only a

Due to en in-

35 per cent increase

in the amplitude of the atrial. contractions was recorded in
response to loO mg of the compoundo

The solvent employed

for some of the compounds (polyethylene glycol) was found
to cause a transient inotropic effect that lasted for
approximately 60 seconds.

Upon administration of the com-

pounds, this same effect occurred before and separate from
the action of the compoundo

Based on the calculated

ED50 ,

methyl 3-acetoxy-2-.Q.-tolylcyclohexylacetate (SH-26) was the
most potent in decreasing the amplitude
atria.

or

the isolated

The ketal of glycerol and 2-.Q.-tolylcyclohexanone was

second in comparative effectiveness, followed by 2-.Q.-tolylcyclohexen-2-one.

Methyl 3-hydroxy-2-.Q.- tolylcyclohexyl-

acetate (SH-24) was the least potento

The mechanism of

action of these compounds on the isolated atria is slightly
different from that of compounds in previous tests.

From

the findings it can be said that there is a great need for
the presence of a bulky substituent at the 3 position

or
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the cyclohexanol ring.

It is better to say that the ..Q.-tolyl

substituent should have a big group in an adjacent positiono
Both methyl 3-acetoxy-2-Q.-tolylcyclohexylacetate and the
ketal of glycerol and
potent.

2-..Q.~tolylcyclohexanone

were the most

It is known that the bulky groups always try to

occupy equatorial positions.

The .Q.-tolyl and the acetoxy

in the first compound and the ketal of glycerol on the
second compound may be occupying an equatorial position to
give the compound the best spatial configuration for its
maximum action.
It is of interest to mention that Smith (1963)1 reported that 2-.Q.-tolylcyclohexen-2-one produced a positive
inotropic effect on the isolated atria in the dosage range
tested.

This is in contrast to the findings in this in-

vestigation.

However, most of the doses employed by Smith

were lower than those employed in this investigation.
Studies with methyl 3-acetoxy-2-.Q.-tolylcyclohexylacetate (SH-26) demonstrated that, following the depressant
action of the compound on the isolated atria, the addition
of calcium.

to

~

the bath restored the amplitude of contrac-

tion of the atria to normal.

These findings are similar to

those reported by Smookler and DeFeo (1962).
In order to determine the effect of the compounds on
smooth muscle, isolated intestinal strips were utilized.
The solvent employed for some of the compounds (polyethylene
glycol) had a transient stimulating effect on the intestine.
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Neither the tone nor the rate of contraction was a.f'fected
by the solvent.

In these experiments, all the compounds

decreased the amplitude of contractions of the isolated
intestine, except 3-hydroxy-2-.Q_-tolylcyclohexylacetic acid
(SH-23), which caused an opposite effect in the dose range
tested (Table XX).
and inconsistent.

?he effects on the rate were variable
All the compounds lowered the tone in

varying degrees except methyl 3-hydroxy-2-.Q_-tolylcyclohexylacetate (SH-24) which did not affect the tone (Table
XVIII).
The results in Tables XVIII to XXII show that the
ketal of glycerol and 2-.Q_-tolylcyclohexanone was the most
potent in depressing the amplitude of contractions and
lowering the tone of the isolated rabbit ileum.
cyclohexen-2-one was the least potent.

2-.Q.-Tolyl-

Thus, substitution

at the number 1 position in the cyclohexanol ring does not
favor the intestinal contraction.

However, once again, a

bulky group at the 3 position is best suited for depressing
the amplitude of the isolated intestine.

The receptor site

may have either a cavity or a flat surface to accommodate
this bulky group.
Several experiments were carried out in an effort to
determine the mechanism of action of these compounds on the
smooth muscle tested.

When acetylcholine was added to the

bath after the depressant action of the ketal of glycerol
and 2-.Q_-tolylcyclohexanone had occurred, it was found that
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the subsequent response of acetylcholine was not diminished;
therefore it appears that the compound is not acting at the
terminal synapses of the parasympathetic nerves.
In other experiments when barium chloride was added
to the bath after the depressant action of the ketal of
glycerol and 2-.Q.-tolylcyclohexanone, the response remained
unchanged.

V.
1.

SUMMARY AND OONCLUSIONS

Several derivatives of 07olohexanol, recentl7 synthesized,
were tested for

v~ioua ph~acological

actions.

The

tests were carried out on intact animals, isolated
ca!'diac tissue, and rabbit small intestine.

The•e

compounds were found to aottvel7 a:f'fect the cardiovascular s7stem and the intestine smooth muscle.
2.

Due to the limited water solubility of some of the compounds, onl7 two derivatives were tested on the blood
pressure.

The results indicate that these compounds

produce a rapid hypotensive
anesthetized rat.

respon~e

on the intact

The magnitude of the effect varied

with the dose administered.

Both

compound~, ~eth7l

3-h7drox1-2-2-tolylo7clohex7laoetate and trans-3-oxo2-.Q.-tol7lc7clohex7laoetio acid., had approximatel7 equal
poteno7.
3.

Experiments conducted on isolated guinea pig hearts
indicate that decreased m1ooardial contractilit1 is
responsible for the oa.rdioplegia produced b7 these
compounds.
hex7lacetate

Both meth7l 3-h7droxy-2-.Q.-tolfloyolo~d

trans-3-oxo-2-Q.-tol7lc7clohex7lacetic

acid exerted the greater cardio-inhibitor1 activity,
and were equally effective, while the ketal of gl7cerol
and 2-.Q.-tolylc7clohexan.one was the least active among
the compouncls studied.
to be cardio-toxic.

None of the compounds appeared
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4.

In the isolated atrial

studies~

the usual response was

a decrease in the amplitude of contraction with no
significant change in the rate of contraction.

Trans-

3-oxo-2-.Q.-tolylcyclohexylacetic acid differed from the
other compounds tested since it produced a positive
inotropic effect on the atrial preparation.
3-acetoxy-2~.Q.-tolylcyclohexylacetate

potent.

Methyl

was the most

Methyl .3-hydroxy-2-.Q.-tolylcyclohexylacetate

possessed the least activity.

'l'll.e negative inotropic

effect of methyl 3-acetox1-2-.Q.-tolylcyclohexylacetate
was antagonized by calcium.

5.

All of the compounds were tested for their action on
isolated intestinal muscle.

All produced depression

of the intestinal preparation, except 3-hydroxy-2-.Q.tolylcyclohexylacetic acid which caused an opposite
effect.

The ketal of glycerol and 2-.Q.-tolylcyclo-

hexanone was

t~e

most potent, while 2-.Q.-tolylcyclohexen-

2-one was the least active on the isolated intestine.
Several experiments with the ketal of glycerol and
2-.Q.-tolyloyclohexanone indicate that
does not

antagoni~e

t~s

compound

the action of acet7lcholine.
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